Biotin supplements (vitamin B7): hair claims and blood test interference

Biotin is a B vitamin that works as a cofactor for enzymes involved in making fatty acids and processing glucose and amino acids. The NHS says it is needed in very small amounts to help the body make fatty acids. MedlinePlus gives an adequate daily intake of 30 micrograms for adults, which is a fraction of what supplement tablets deliver.

It is present in egg yolk, legumes, nuts, organ meats and yeast, so true deficiency is rare in people who eat normally.

MedlinePlus lists skin rashes, hair loss and brittle nails among the signs of biotin deficiency. That is the origin of the hair, skin and nails marketing. Deficiency can occur in people who eat large quantities of raw egg white, on long-term unbalanced artificial feeding, with some anticonvulsant use, or with the inherited condition biotinidase deficiency, which is picked up in newborn screening and treated lifelong.

For people with normal biotin status, neither the NHS nor MedlinePlus presents supplements as a treatment for thinning hair or weak nails, and hair loss has many other causes, including iron deficiency, thyroid disease and hormonal change, that deserve a proper assessment.

Many hospital analysers use a streptavidin-biotin link to capture the substance being measured. If the sample contains a large amount of free biotin, it competes for the binding sites. A 2025 laboratory study explains the result: in sandwich assays, such as TSH and troponin-type designs, excess biotin lowers the signal and gives a falsely low result, while in competitive assays, such as free T4, it can give a falsely high result.

The practical danger is a misleading pattern. A person taking biotin can appear to have an overactive thyroid when it is normal, or low tumour-marker values when it is not, and troponin results used to assess chest pain can be falsely low in some assay systems. That is why laboratories and clinicians are advised to ask about supplements when results do not fit the clinical picture.

Dose matters. The 2025 study cites peak blood biotin of 41, 91 and 184 ng/mL after 5, 10 and 20mg doses in healthy volunteers, and found that levels above about 500 ng/mL changed some results by 20 percent or more. High-dose biotin used experimentally for multiple sclerosis produced much higher levels. Typical hair-and-nail products come in the milligram range, so they sit well above dietary intake and in the zone where interference becomes possible. Newer assay versions tolerate more biotin, and some manufacturers’ platforms are more resistant than others.

• Tell the doctor, nurse or phlebotomist if you take biotin, even in a multivitamin or hair product.

• Ask whether to stop beforehand; published advice ranges from at least 72 hours to at least one week.

• Do not stop prescribed biotin for a medical condition without asking your specialist.

• If a result seems out of keeping with how you feel, ask for it to be repeated after a break from supplements.

People on regular high-dose biotin, those on kidney dialysis and some intensive care patients have been found to have raised levels. Thyroid testing is the commonest example in outpatients, so people being investigated for thyroid disease are advised to be open about supplements, as an inappropriate diagnosis or treatment change is the main risk.

MedlinePlus says there are no known toxic symptoms from biotin, and the NHS says it does not know what high daily doses might do. The reasonable reading is that biotin is low in direct toxicity but not free of consequences, because of the laboratory problem above.